Announced Thu, 30 Apr · 16:44 IST

<b>Format of Initial Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=''1px''><tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> <td><b>Details</b></td> ....

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
-9.6%1-day move
₹6.90
prior close
₹6.56
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.0+0.0+0.0+0.0-9.6-5.1-0.4-5.4-10.0-10.1-18.8-25.8-18.3
Up moveDown movePending
AI summary

Arunjyoti Bio Ventures Ltd filed an Initial Disclosure with BSE clarifying that it does NOT qualify as a "Large Corporate" under SEBI's framework. The company meets only one of the three required conditions: having equity shares listed on BSE. It does not meet the other two criteria: outstanding long-term borrowings of ₹1,000 crore or more, and possessing a credit rating of "AA" or above for unsupported bank borrowings or plain vanilla bonds. As a result, the requirement to file an Initial Disclosure for financial year 2026-2027 is not applicable to the company. The filing was signed by P.B.N. Murthy, Whole-Time Director, and dated April 30, 2026.

Likely market impact

No direct financial impact on shareholders. This is a negative disclosure confirming the company is exempt from Large Corporate disclosure requirements due to not meeting the debt and credit rating thresholds.